Here's a combined rationale that incorporates the best of each individual rationale:

The current status quo outcome is that humans are not immortal, and aging will continue to occur. This is because biological processes are complex and multifaceted, making it challenging to develop effective treatments for age-related diseases. Additionally, the pace of medical advancements can be slow due to various factors such as funding constraints, lack of understanding of the aging process, or unforeseen challenges.

However, there are scenarios where significant breakthroughs could lead to human immortality by 2030. These might involve advancements in AI, biotechnology, and regenerative medicine, which could accelerate progress in understanding and reversing the aging process. The convergence of various scientific disciplines, increased investment in research, and the emergence of new technologies that accelerate progress could also contribute to breakthroughs.

While it is possible that significant challenges and uncertainties will persist, there is a chance for rapid development and deployment of treatments that slow down or reverse aging if breakthroughs are made in AI and biotechnology. The rapid pace of advancements in these areas could lead to the development of regenerative therapies, senolytic treatments, or even a merging with artificial intelligence that enables humans to live indefinitely.

Overall, while the status quo outcome is more probable, there is a possibility for significant breakthroughs to be achieved within the next 5 years. A balanced approach considering both the challenges and opportunities in this area provides a more nuanced understanding of the likelihood of human immortality by 2030.

### Probability: 20%